You own the rights to a biotech drug. Your best estimate is that the current value of these rights is $50 million. Assuming that the annual volatility of biotech companies is 90 percent and the risk-free rate is 5 percent, what is the value of an option to sell the rights to the drug five years from now for $40 million?